NCT00928668 - Efficacy (Bronchoprotection) and Safety of Orally Inhaled BI 1744 CL in Patients With Intermittent Asthma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

October 31, 2006

Conditions

Asthma

Interventions

DRUG

Placebo

Placebo device for comparison

DRUG

Olodaterol (BI1744CL)

Olodaterol comparison of low, medium low, medium high and high doses

DRUG

Olodaterol (BI1744CL)

Olodaterol comparison of low, medium low, medium high and high doses

DRUG

Olodaterol (BI1744CL)

Olodaterol comparison of low, medium low, medium high and high doses

DRUG

Olodaterol (BI1744CL)

Olodaterol comparison of low, medium low, medium high and high doses

Trial Locations (4)

1222.4.103 UBC - Respiratory Medicine, Vancouver

1222.4.104 Department of Medicine, Health Sciences Centre, Hamilton

1222.4.101 2725 Chemin Ste Foy, Sainte-Foy

1222.4.102, Saskatoon